INTRODUCTION
Polycystic kidney disease (PKD) is a progressive genetic disorder of the kidney. It is characterized by the presence of multiple cysts in both kidneys and ultimately leads to end-stage renal disease (ESRD). By inheritance, PKD exists as two major forms: autosomal recessive (ARPKD) and autosomal dominant (ADPKD). ARPKD is a significant hereditary renal disease in childhood, with estimated prevalence of 1 in 20 000 live births. A carrier frequency of up to 1:70 has been proposed (1) . Classic ARPKD is generally defined as an infantile disorder with diagnosis in utero or within the neonatal period, which presents with greatly enlarged echogenic kidneys. Some patients are diagnosed after neonatal age, which form an older group. In the classic group, most patients have renal insufficiency and ESRD at birth. The older group more often involves liver manifestations, including hepatosplenomegaly, variceal bleeding and cholangitis. Some patients with the diagnosis of ARPKD at 1 year of age with nephromegaly exhibit slow renal function decline over 20 years with only minimally enlarged kidneys at ESRD and markedly atrophic kidneys following renal transplantation (2) . The slow progression of renal disease is likely due to increasing fibrosis, rather than the development of cysts. Genetic linkage studies indicate that mutations within a single gene, PKHD1, mapped to the human chromosome region 6p21.1-6p12.2, are responsible for all the clinical presentations of ARPKD (1, 3) . PKHD1, cloned independently by three groups (4-6), encodes fibrocystin/polyductin (FPC), which is a large receptor-like integral membrane protein of 4074 amino acids. † These authors are equal contributors. * To whom correspondence should be addressed. Tel: +1 6175255860; Fax: +1 6175255861; Email: zhou@rics.bwh.harvard.edu # The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org Human Molecular Genetics, 2010, Vol. 19, No. 17 3306-3319 doi:10.1093/hmg/ddq233 Advance Access published on June 16, 2010 FPC contains a signal peptide, a large N-terminal extracellular region, a single transmembrane domain and a short intracellular cytoplasmic domain (ICD). We and others have previously reported subcellular localizations of FPC (7 -10) . A consensus finding is that FPC is localized in the primary cilia of kidney tubular epithelia cells and cholangiocytes of bile ducts. It has been shown that disruption of Pkhd1 by a germ line mutation in the PCK rat results in abnormalities in primary cilia of cholangiocytes (11, 12) . Some reports have also shown FPC localization on the basal body (7, 9) and plasma membrane (10, 13) .
The large extracellular domain of FPC is presumed to bind to a yet unknown ligand(s). The C-terminal ICD of FPC harbors a nuclear localization signal and may be cleaved and translocated to the nucleus in cells stimulated with protein kinase C activator or Ca 2+ ionophore which increases intracellular Ca 2+ (14) . FPC interacts with polycystin-2 (PC2), whose gene is mutated in the ADPKD. This interaction may occur between the ICD of FPC and the amino terminal ICD of PC2 (15) or through a third binding partner, such as kinesin-2 (16) . Downregulation of PC2 in the mice with hypomorphic Pkd2 alleles (Pkd2 nf3/nf3 ) is accompanied by a phenotype similar to that of Pkhd1 2/2 mice (15), all of which support the hypothesis that there is a common mechanism underlying cystogenesis in AD-and ARPKD. In ciliated terminally differentiated cells, FPC may form a complex with polycystins and modulate Ca 2+ signaling in response to extracellular fluid flow stimulation (13) . Misorientation of the mitotic spindle has recently been proposed to cause cyst formation in pck rats, an orthologous model of human ARPKD (17, 18) , although the importance of spindle orientation in cystogenesis was questioned because of the absence of cysts in Pkhd1 knockout mice with misorientated mitotic spindles at 1 year of age (19) . The role of FPC during cell division and differentiation remains unclear.
In the present study, we found that endogenous FPC localizes to the centrosome and mitotic spindle in human and mouse renal epithelial cells by using two specific FPC antibodies. Knockdown of FPC in canine and mouse epithelial cells by short-hairpin-mediated RNA (shRNA) leads to multipolar spindles in mitotic cells and multiple centrosomes in interphase cells. Multiple centrosomes can also be detected in tubular epithelial cells in ARPKD kidneys, similar to those in human ADPKD kidneys (20) . Thus, we report a new subcellular location for FPC and a novel role of FPC in the regulation of centrosome duplication and mitotic spindle assembly.
RESULTS

Construction of a full-length human FPC expression construct
The longest ORF of PKHD1 is transcribed from 67 exons that encode a transmembrane protein containing 4074 amino acids. Thus, we strategically amplified four overlapping DNA fragments by PCR from cDNA synthesized from human fetal kidney RNA using specific FPC primers. These four fragments were then assembled sequentially utilizing unique restriction enzyme sites shared by the overlapping fragments in pcDNA4/TO/myc-His B vector to make a full-length PKHD1 cDNA expression construct with a myc/His tag fused in frame at the C-terminus of FPC (Fig. 1A) . F4 set of primers amplified two different sizes of PCR products and the expected longer product was used for making the fulllength construct.
Establishment of cell lines stably expressing full-length FPC in an inducible fashion in T-REx 293 and LLC-PK1 cells
To establish FPC stable expression cell lines, we transfected the full-length FPC construct into T-REx 293 cells and used Zeocin as a selective agent. A total of 12 clones were picked and the clone with the highest expression level of full-length FPC was named hFPCT and chosen for later experiments. The expression levels of FPC in hFPCT cells were verified by western blot (Fig. 1B) and immunostaining (data not shown) using our well-characterized antibody raised against an N-terminal epitope of FPC (804) (7) and anti-myc antibody that recognizes the myc tag at the C-terminus of recombinant FPC. The data show that the high molecular band that is overexpressed in the induced hFPCT but not in empty vectortransfected control T-REx 293 (P4T) cells represents recombinant FPC (Fig. 1B) . A slight leakage expression could be seen sometimes in the non-induced hFPCT cells. A similar approach was used to establish a stable FPC expressing line in porcine renal tubular epithelial (LLC-PK1) cells which was named hFPCL thereafter. Stable expression of FPC in hFPCL cells was confirmed by immunostaining (Supplementary Material, Fig. S1 ) and western analysis with myc tag (Fig. 1C , right panel) and 804 antibodies (data not shown) under tetracycline-induced conditions. Both 4883 and anti-myc tag antibodies can detect, in addition to the high molecular weight 500 kDa FPC bands, two small bands about 70 and 50 kDa, which may be cleavage or degradation products of PFC. As expected, recombinant FPC can be detected on the primary cilia in post-confluent LLC-PK1 cells using anti-myc tag antibody (Supplementary Material, Fig. S2A ).
Generation and characterization of a specific rabbit anti-human FPC polyclonal antibody
To develop an antibody against the entire human FPC C-terminal ICD, we generated a GST -FPC fusion protein by inserting the last 192 amino acids of FPC to the C-terminus of GST protein. Antisera were affinity-purified using the GST -FPC fusion protein. The resulting purified FPC antibody was named 4883. The sensitivity and specificity of 4883 were tested by western blotting (Fig. 1D) and immunostaining ( Fig. 1E ) in hFPCT cells that overexpress recombinant fulllength FPC. Like 804 antibody, 4883 recognizes a high molecular weight band in induced hFPCT cell lysates as well as in immunoprecipitates of FPC antibody 804 or myc tag antibody (Fig. 1D) .
The sensitivity and specificity of FPC antibody 4883 were further verified by both western blot (Fig. 1C ) and immunostaining (Fig. 1F ) in renal epithelial cell line LLC-PK1 that stably expresses FPC. In contrast to the absence of signals in non-induced cells (Fig. 1F panels a -c (Fig. 1G panel e) , demonstrating the specificity of the blocking experiments.
Endogenous FPC localization on the mitotic spindle and centrosome
Although FPC has been reported to localize to the plasma membrane, basal body and cilia (7 -10) , its localization during mitosis was not determined in previous studies. We used acetylated a-tubulin antibody (green) and DAPI (blue) to visualize the mitotic spindle and the chromatin/DNA, respectively, in cells during different phases of mitosis. In MDCK and mIMCD3 cells at prophase, FPC appeared to be present around the microtubule organizing center (MTOC) ( These results suggest that FPC may be associated with microtubule-based structures important for mitotic progression and cytokinesis. We noticed that the signal on the midzone area was weaker than that on mitotic spindle, suggesting that the expression level of FPC around the microtubule-based structures (MTOC, spindle and midbody) may be cell cycle phase-dependent. Since the amino acid sequence identity 2C panel d) . In contrast, the signal (in red) remained when 4883 was preincubated with GST protein alone ( Fig. 2C panel a) . Since localization of FPC on the mitotic spindles is an unprecedented finding, we also examined FPC subcellular localization in dividing cells in other cell lines, including HEK293 ( The centrosome is an organelle that serves as the main MTOC. Centrosome-nucleated microtubules interact with chromosomes to build the mitotic spindle during mitosis. Since endogenous FPC is found on the mitotic spindle and in basal bodies in differentiated cells (7), we asked if FPC is also localized to the centrosome in dividing or interphase cells. We performed double labeling of g-tubulin with 4883 or with 803 that was raised against a 14-residue peptide (KRRESQGPKKEDTV) in the ICD of human FPC (7) 
FPC knockdown and its efficiency
To investigate the potential role of FPC localization at the mitotic spindle and the centrosome during various cell phases, we attempted to knockdown endogenous FPC by shRNA in MDCK cells. We made six shRNA constructs to five target sites in FPC. Among which, three lentiviral shRNA constructs were designed to specifically target three sites (S1 -3) in canine PKHD1 cDNA (Fig. 4A ). Their efficiency was tested by infecting hFPCL cells that stably overexpress FPC ( Fig. 4B ). Viral infection with shRNA targeting to the third site (S3) in the 3 ′ -untranslated region of PKHD1 was not successful. S1 sequence is specific to canine PKHD1 but has 85.7% nucleotide identity with the human sequence. S2 sequence is identical between canine and human PKHD1 cDNA. Consistent with species specificity, S2 lentiviral infection clearly inhibited overexpression of human full-length FPC in hFPCL cells (Fig. 4B , lane 4), whereas shRNA specific to canine FPC site S1 displayed no obvious inhibitory effect (Fig. 4B, lane 3) , similar to the scramble sequence control (SC) or the parental non-infected cells (Fig. 4B, lanes 1 and  2) . FPC knockdown in hFPCL cells is also evident as indicated by the loss of FPC signals detected by either 4883 (green) or myc antibody (red) in S2 but not SC-infected hFPCL cells (Fig. 4C) , suggesting S2 sequence works well in depleting human recombinant FPC. To test the efficiency of FPC knockdown constructs on canine FPC, we cloned a fragment of canine PKHD1 cDNA and transiently expressed a mini-FPC (M-FPC) that encodes the first N-terminal 700 residues of canine FPC. In contrast to two additional canine PKHD1 shRNA target sequences in the pSilencer 2.1 system (S4 and S5), S1 shRNA strongly inhibited myc-tagged recombinant canine FPC peptide (Fig. 4D, lane 6) .
We went on to test the knockdown efficiency of the S1 shRNA construct on the endogenous FPC in MDCK cells. At the protein level, FPC expression is significantly decreased, including the high molecular weight bands (Fig. 4E, arrows) at the size similar to the hFPC-myc recombinant protein, in S1 knockdown cells compared with the parental MDCK cells and scramble control (SC) cells (Fig. 4E, lanes 1 and 2) . Unlike S1, FPC depletion by targeting to the S2 site was not effective in MDCK cells (Fig. 4E) . To determine the knockdown effect at the S1 site at the transcript level in MDCK cells, we performed semi-quantitative PCR and real-time quantitative PCR, by amplifying two fragments of FPC cDNA, located at either the 5 ′ (F5) or 3 ′ portion (F6) of PKHD1 cDNA sequence (Fig. 4A) . Semi-quantitative PCR of F5 and F6 fragments of PKHD1 transcript with 30 but not 35 cycles showed a significant reduction in PKHD1 transcript in S1 lentiviral-infected cells compared with SC-infected cells (data not shown). Real-time PCR showed a significant reduction in FPC F5 and F6 fragments to about 37 and 30% (Fig. 4F ) in S1 knockdown cells, compared with SC cells. Therefore, we selected S1 shRNA lentivirus for later FPC knockdown experiments.
FPC knockdown in MDCK and mIMCD3 cells induces multiple defects in mitosis
In FPC knockdown MDCK cells, we detected a significant reduction in the FPC signal on the mitotic spindle in dividing cells (Fig. 5A panel e and i compared with a) . Interestingly, dividing cells with reduced FPC expression also display mitotic defects such as multipolarity and chromosomal lagging (Fig. 5A panel g and j, k compared with b and c). Because the number of dividing cells in a random culture is low, we went on to synchronize the cells using RO-3306, a CDK1 inhibitor, to obtain a sufficient number of dividing cells for statistic analysis. RO-3306 arrests the cells at late G2 phase and after washout, cells released from this chemical will enter mitosis. We surveyed 647 dividing cells by average from three independent experiments after 18 h synchronization with RO-3306 and found 25.3% of them with three, four or five spindle poles in FPC S1 knockdown MDCK cells, whereas only 3.9% of the 474 dividing cells infected with SC control lentivirus we examined showed multipolar spindles (Table 1) . This difference is statistically significant (Fig. 5B) . In contrast to the normal bipolar division in WT4 control cells ( It is noteworthy that, in FPC knockdown mIMCD3 cells, spindle multipolarity is an even more prominent phenomenon than that in MDCK knockdown cells, with a high ratio of 47.96%, in comparison with 3.85% in the WT4 control (Table 1 and Fig. 5D ). When we stained FPC knockdown mIMCD3 cells at interphase with g-tubulin, we noticed that some cells have multiple centrosomes. The number of FPC knockdown cells with multiple centrosomes (three or more centrosomes) was even higher after RO-3306 synchronization, in comparison with WT4 control cells (Fig. 6A) . Among a total of 557 cells we surveyed, 42.1% of the FPC knockdown cells showed multicentrosomes, whereas only 5.57% of the 544 control cells had multicentrosomes (Table 2) .
Multicentrosomes in kidneys from human ARPKD patients
Since we have observed centrosome amplification in FPC knockdown cells, we attempted to verify this aberrant cell phenotype in vivo in human ARPKD patients. We performed Human
double immunostaining with two specific centrosomal markers, g-tubulin (green) and pericentrin (red), on ARPKD kidney sections from several patients, whose ages ranged from 9 days (3/ 99 1A) to 13 years (27/99A). Despite that the sections available to us were only 4 mm thick and had severe cysts, multicentrosomes were readily detectable in some ARPKD kidney tubules ( Fig. 6B and Supplementary Material, Fig. S5 ). In control kidneys, we normally detected only one, occasionally two centrosomes but we have never detected multicentrosomes ( Fig. 6B and Supplementary Material, S5 ). This evidence suggests that the dysregulation of centrosome number is not confined to FPC-depleted cells. It is remarkable that multiple centrosomes were observed in the epithelial cells of seemingly normal tubules (Fig. 6B, right panel) and in the cyst-lining collecting tubule epithelial cells (Supplementary Material, Fig. S5 , right panel). The fact that the mitotic spindle defects are seen in normal looking tubules suggests that centrosome amplification may be one of the preceding events that contribute to renal cyst formation. Surprisingly, we could not see clear g-tubulin staining on the kidney sections from a 9-day-old patient (data not shown), under the same experimental condition as other patients. Moreover, in the kidney from a 5-year-old ARPKD patient (No. T49/93D), we observed a number of g-tubulin positive dots in DBA-positive tubules. These data provide us with a hint that FPC could also be involved in the pathway of centrosome biogenesis and maturation. 
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DISCUSSION
In this study, we report the generation of a new FPC antibody 4883 raised against the recombinant protein encoding the Cterminal cytoplasmic tail of FPC. Using this antibody, we showed for the first time the localization of endogenous FPC on the mitotic spindle in renal epithelial cell lines of proximal tubule and collecting duct origin (MDCK, mIMCD3, RCTEC and LLC-PK1) and in multiple species (human, porcine, canine and mouse). FPC is also found on the mitotic spindle of HEK293 cells, a cell line commonly used for gene transfection and expression studies. The specificity of the immunofluresence signal on the mitotic spindle was verified by pre-incubation with respective immunogens and by FPC depletion by shRNA. The localization of FPC on the mitotic spindle was also confirmed by another FPC-specific antibody 803 raised against the C-terminal cytoplasmic tail of FPC (7). In this study, we also generated a full-length FPC expression construct with a C-terminal myc tag and stably expressed this construct in renal epithelial cells (LLC-PK1) and T-REx 293 cells. Ciliary expression of the full-length recombinant FPC is detectable with 4883 antibody or anti-tag antibody in 3 -7-day post-confluent cells (Fig. 2S ) and the signal is stronger in 7-day post-confluent cells. These data suggest that, like the endogenous FPC, the recombinant full-length FPC has a proper ciliary localization in differentiated cells. We could not detect exogenously expressed FPC on the mitotic spindle using anti-myc tag antibody (Supplementary Material, Fig. S2B panel g ). Several possibilities may account for the absence of full-length recombinant FPC on the mitotic spindle. One possibility is that recombinant protein undergoes different post-translational modifications compared with the endogenous protein, which prevent its localization on the mitotic spindle; the other possibility is that the form of FPC that goes to the mitotic spindle is not a full-length protein; instead, it is a shorter isoform that contains the ICD recognized by 4883 antibody. Evidence supporting the latter possibility includes the fact that FPC-specific antibody 804 (7) raised against an epitope located at the Nterminal extracellular domain failed to detect endogenous FPC on the mitotic spindle and the centrosome (data not shown and Supplementary Mateial, (803) could detect FPC on the centrosome and mitotic spindle. Like its human counterpart, the mouse Pkhd1 is a large gene occupying approximately 500 kb of genomic DNA and includes a minimum of 68 non-overlapping exons. It undergoes complex alternative splicing, and its translation products have very similar properties, such as the tissue expression pattern and protein identity, to its human ortholog (21) . These alternatively spliced transcripts probably encode multiple protein isoforms lacking different combinations of exons encoding parts of the extracellular domain of FPC and are expressed in various tissues and at distinct subcellular locations with specific biological functions (10) . Indeed, western blotting analyses also showed that there are multiple bands recognized by FPC antibodies (8, 10, 11, 13) .
The bipolarity of the mitotic spindle is essential for accurate segregation of chromosomes into two daughter cells during cell division (22) . We found that FPC depletion causes multipolarity in both canine MDCK and mouse IMCD3 cells, suggesting that FPC is needed in the normal bipolar mitosis. Multipolarity is usually a phenomenon associated with an increase in centrosome number. Indeed, a number of cells with FPC depletion have multiple centrosomes during interphase. We and others have previously shown FPC localization on basal bodies and primary cilia (7) (8) (9) (10) . Given the localization of FPC on mitotic spindles and centrosomes, it is tempting to speculate that FPC is required for bipolar cell division through the control of centrosome numbers. Increased centrosome number may result from centrosome splitting or increased duplication during the cell cycle. Using antibodies to centrin-2 and g-tubulin, we found that each g-tubulin-positive centrosome in FPC knockdown cells contains two normal size centrioles as marked by centrin-2 (data not shown). Therefore, FPC likely regulates correct centrosome duplication and mitotic spindle assembly to ensure normal bipolar cell division.
Mouse embryonic fibroblasts lacking tumor suppressor p53 often undergo centrosome amplification. Mouse fibroblasts null for both p53 MdmX had increased incidence of multipolar mitosis relative to p53-null cells (23) . One of the proposed mechanisms explaining p53 regulation of centrosomes involves the p53 transcriptional target gene, p21 (24) . Transient overexpression of cyclin D1 in hepatocytes and breast epithelial cells induces centrosome amplification, mitotic spindle abnormalities and aneuploidy, which are associated with upregulation of p53 and p21 (25) . This mechanism may be involved in ARPKD as we were able to detect upregulated cyclin D1 expression in FPC-depleted mIMCD3 cells (Fig. 6A, right panel) and increased p21 levels in ARPKD patients. Consistently, application of CDK1 inhibitor RO-3306 seems to enhance the multipolarity phenotype in FPC knockdown cells (data not shown).
The fate of cells with multipolarity is still unclear but various outcomes are possible. In a cell with an even number of spindle poles, if the poles coalesce back together, the cell might divide in a bipolar fashion producing two daughter cells. In a cell with an odd number of poles, the cell might divide into more than two cells with an unequal number of poles observed during metaphase. In addition, the cell might arrest without ever completing cytokinesis. Multipolarity is considered a major source of genomic instability since it is almost impossible for the daughter cells to acquire proper distribution of chromosomes (i.e. chromosome lagging) even if only two daughter cells are produced following multipolar mitosis (26) .
Our results indicate that FPC localizes to the centrosome and mitotic spindle during cell division. This finding is verified by the indirect immunofluorescence of endogenous FPC in several different cell types, antigen blocking experiments and FPC RNA interference (RNAi) experiments in mIMCD3, MDCK and HEK293 (data not shown) cells. Moreover, we are not able to rescue the phenotype by inducing the full-length FPC in HEK293 cells (data not shown), which is consistent with our hypothesis that the isoform that is responsible for this phenotype is unlikely to be full-length FPC. We could not detect the recombinant full-length FPC on either the mitotic spindles or the centrosomes. The multiple centrosomes and aberrant mitotic spindles in FPC knockdown cells indicate 
that at least an isoform of FPC may be required in centrosome maturation, centrosome integrity and mitotic spindle assembly. The overduplication of centrosome, multipolarity in kidney tubular cells after FPC depletion can lead to genomic instability, and subsequently contribute to the hyperproliferation and hyper-apoptotic phenotypes seen in cyst-lining epithelial cells and increased fibrosis in PKD. The link of FPC with centrosome integrity and genomic instability may have profound implications on the pathogenetic mechanisms of ARPKD and contribute to the clinically seen phenotypic variability.
The major ADPKD protein polycystin-1 (PC1) was recently reported to be involved in the maintenance of centrosome duplication. Depletion of PC1 in a cellular system is sufficient to produce centrosome amplification and multipolar spindle formation, leading to genomic instability characterized by gross polyploidism and mitotic catastrophe. Significant centrosome amplification was also seen in kidneys from conditional Pkd1 knockout mice and human ADPKD patients (20) . Cyst-lining cells from ADPKD kidneys also have a high frequency of abnormalities on numerous chromosome regions Human 27) . Centrosome amplification and mitotic instability were also found in PC2 transgenic lines (28) . These data provide further evidence that FPC may act in a common pathway with the polycystins. We and others have shown that FPC interacts with PC2, which has also been reported to localize to the mitotic spindle during cell division (29) . More recently, two Meckel syndrome (MKS)-associated proteins, MKS1 and MKS3, are both localized to the basal body and cilium and appear to regulate appropriate cilia length and number through modulating centrosome duplication (30) . Collectively, it is tempting to hypothesize that at least some proteins known as ciliary proteins in differentiated cells may also function in centrosome duplication and spindle assembly in cells during cell cycle as a result of an energy saving mechanism for the cell to share cellular components. In summary, we have identified unexpected localization of FPC on mitotic spindles and its function in bipolar cell division for the first time. Together with our knowledge of the defects in planar cell polarity and mitotic spindle orientation in the rat model of ARPKD (17), we propose that FPC may form a signaling complex at the spindle pole with other cystogenic proteins and modulate mitotic spindle orientation and bipolarity during mitosis, in addition to their role in primary cilia in fully differentiated cells.
MATERIALS AND METHODS
Cloning of human PKHD1 full-length cDNA
Four overlapping FPC cDNA fragments were amplified with high-fidelity DNA polymerase (PfuUltra TM High-Fidelity DNA Polymerase; Stratagene) from a human fetal kidney cDNA library. All four fragments were verified by doublestrand sequencing before assembling into the longest ORF cDNA (12222bp, 4074 amino acids) by using unique restriction enzyme sites common to the overhang segments. The fulllength cDNA was sequenced again to confirm PCR fidelity. The primers used are shown as follows: fragment 1 (2572 bp) forward: atgccttaagagaatgactgcctggctgactctctgatg; reverse: actggcggccgcccccaatctgagtggaccaggacaaggtcc. Fragment 2 (3668 bp) forward; gacgacacagagacgacagcggacaagtcc acctctaggaggacactttcgc; reverse: actggcggccgccaatccggagctct ccaccatcagaaacaaggatggcgtgtgccctgagc. Fragment 3 (2851 bp) forward: gggggcaagctgattttcatggccccaggaccc; reverse: actggcg gccgcggtggcccttgacttctttcacagtgaggacc. Fragment 4 (3625 bp) forward: atgccttaagagactcctggacacatcttggagctgatattgc; reverse actggcggccgcgcagttgctcctgaatagtttccgggtgtactgaatgaaggc.
Generation of FPC-specific antibody
Human FPC ICD (192 amino acids, named hFPC-ICD) was cloned into pGEX4T1 GST expression vector (Amersham Pharmacia). GST-hFPC-ICD plasmid DNA was transformed into BL21/DE3 Escherichia coli and cultured in LB medium with IPTG induction to produce GST -hFPC-ICD fusion protein. The purified GST fusion protein was injected into two rabbits to produce antisera. After verified to recognize the antigen by immunofluorescence and Western blot, the polyclonal antiserum was affinity-purified by GST-hFPC-ICD coated sepharose (Invitrogen). This affinity-purified FPC antibody was named 4883. 
Immunofluorescence staining
Cells were seeded onto the 22 or 15 mm cover slips (Warner Instruments) in six-well or 12-well plates (Corning) and cultured for 1 -2 days until cells were at appropriate confluence. The cells were fixed with 3.7% FPA plus 2% sucrose for 20 min at RT, then rinsed twice in 1× PBS, permeabilized with 0.25% -0.5% Triton X-100 (in 1× PBS) for 5 min, rinsed twice more in 1× PBS and blocked for 1 h in 1× PBS containing 10% BSA and 2% goat serum. For g-tubulin staining, cells were treated with cold methanol for 3 min at 2208C followed by 10 min PFA fixation. After incubated with primary antibodies overnight at 48C, washed three times with 1× PBS, the cells were then incubated with Alexa Fluor 488 (Green; Invitrogen, Cat. No. A11001), Alexa Fluor 594 (Red; Invitrogen, Cat. No. A11012) conjugated secondary antibodies for 1 h at RT, washed three times with 1× PBS and mounted with Prolong Gold antifade reagent with DAPI (Invitrogen, Cat. No. P36935). Antibodies were diluted in blocking buffer with the following concentrations: mouse anti-acetylated-a-tubulin (1:20 000; Sigma, Cat. No. T6793), mouse anti-g-tubulin (1:10 000; Sigma, Cat. No. T6557), rabbit anti-human FPC 4883 (raised to human ICD, encoded by exons 65-67) (1:300), 804 (1:100), and 803 (raised to a peptide encoded by exon 66) (1:100), chicken anti-mouse FPC 5249 (raised to a peptide encoded by mouse exon 67) (1:100) and anti-myc antibody (1:1000). In an antigen blocking experiment, 4883 antibody was preincubated with same molar amount molecules of GST and GST -hFPC -ICD fusion protein separately for 1 h, followed by the same staining protocol. Images were acquired by PKHD1 knockdown PKHD1 shRNAi target 1 (S1) is located in exon 16 of canine sequence: aagcatcaaatccgagtccgt, corresponding sequence in human: aagcaccagatccgagtccga. S1 and two other PKHD1 shRNAi target sequences S4, S5 and a scramble sequence control were subcloned into pSilencer 2.1 vector (Ambion), then co-transfected into T-REx 293 cells with the canine FPC mini-construct which contains the most N-terminal 700 amino acids of FPC in pcDNA4/myc/His B vector. The expression of this M-FPC was confirmed by western blot. S1 showed 90% inhibition of the M-FPC when compared with the scramble control. Thus, we used S1 sequence as one of the targets for lentiviral shRNA knockdown experiments.
We used pLKO.1 lentiviral vector for expressing FPC shRNAs (S1 -S3). The vector was digested with two restriction enzymes, AgeI and EcoRI, and the following oligonucleotides were annealed and inserted between the Agel and EcoRI sites under the control of a U6 promotor. These canine oligo nucleotide sequences are: S1 forward: ′ . S2 sequence is identical to its human counterpart. These PKHD1 shRNAs in pLKO.1 lentiviral vector were converted into lentiviral particles by transient transfection into T-REx 293 cells, and then transduced into MDCK cells at 50% confluence. Stable selection was performed with 4 mg/ml puromycin at about 40 h post-transduction. RT-PCR and real-time PCR showed that S1 has a higher efficiency than S2 in knockdown of the endogenous FPC in MDCK cells, thus S1 was used for the later experiments in MDCK cells.
We also used PKHD1 knockdown mIMCD3 cell line (S26) (13) . In this cell line, Pkhd1 was targeted by shRNA at exon 21 from nucleotide 2141 to nucleotide 2161. Accordingly, we named its empty vector control cell line as 'WT4'. ShRNA (Ambion) was cloned into pSilencer2.1 vector. The target sequence is: sense strand: AGGCTCTTCCAGAATCA GCTT; anti-sense strand: AAGCTGATTCTGGAAGAGCCT.
Semi-quantitative and real-time PCR
Two canine PKHD1 cDNA fragments, F5 at nucleotide positions 1381 -1627 and F6 at nucleotide positions 7506 -7752, were used for testing S1 knockdown efficiency 
